Trials / Terminated
TerminatedNCT00628797
Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis
Multizenter-Studie Zur UVA-1 Therapie für Die Hautbeteiligung Bei Systemischer Sklerodermie
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Nicolas Hunzelmann · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Systemic scleroderma (SSc) is a rare chronic inflammatory diseae of the connective tissue involving the skin and internal organs. To date there is no proven therapy for the skin fibrosis available. A number of case reports and small uncontrolled cohort studies suggest that UVA1 therapy may improve skin fibrosis. The aim of this study is therefore to investigate whether treatment UVA1 in deed is effective in treating skin fibrosis in SSc using a randomized, intraindividual half body irradiation protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | UVA1 | intraindividual half body irradiation |
| OTHER | UVA1 | 60 J/cm2 at least 36 tx |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2010-07-01
- Completion
- 2013-11-01
- First posted
- 2008-03-05
- Last updated
- 2017-05-31
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00628797. Inclusion in this directory is not an endorsement.